Literature DB >> 16283991

How high is the non-response rate of patients referred for eye examination from diabetic screening camps?

Swati Agarwal, Sheshadri Mahajan, Padmaja Kumari Rani, Rajiv Raman, Pradeep G Paul, Govindasamy Kumaramanickavel, Tarun Sharma.   

Abstract

AIM: To elucidate the rate of non-response among diabetics (recently diagnosed in rural diabetic screening camps) who were referred for eye examination to detect diabetic retinopathy.
METHODS: At diabetic retinopathy screening camps, all patients underwent dilated fundus examination using binocular indirect ophthalmoscopy.
RESULTS: Of the 4,111 known diabetics, only 2231(55%) patients attended the diabetic retinopathy screening camps. Likewise, of the 1076 newly detected diabetics, only 125 (11.6%) attended the diabetic retinopathy screening camps.
CONCLUSIONS: Non-response of such a magnitude calls for creating greater awareness among masses on diabetes and its microvascular complications. Second, conducting simultaneous diabetes screening and diabetic retinopathy screening camps could minimize the dropout rate.

Entities:  

Mesh:

Year:  2005        PMID: 16283991     DOI: 10.1080/09286580500278418

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  2 in total

1.  Systematic review on barriers and enablers for access to diabetic retinopathy screening services in different income settings.

Authors:  Mapa Mudiyanselage Prabhath Nishantha Piyasena; Gudlavalleti Venkata S Murthy; Jennifer L Y Yip; Clare Gilbert; Maria Zuurmond; Tunde Peto; Iris Gordon; Suwin Hewage; Sureshkumar Kamalakannan
Journal:  PLoS One       Date:  2019-04-23       Impact factor: 3.240

2.  A qualitative study on barriers and enablers to uptake of diabetic retinopathy screening by people with diabetes in the Western Province of Sri Lanka.

Authors:  Mapa Mudiyanselage Prabhath Nishantha Piyasena; Gudlavalleti Venkata S Murthy; Jennifer L Y Yip; Clare Gilbert; Tunde Peto; Mahesh Premarathna; Maria Zuurmond
Journal:  Trop Med Health       Date:  2019-05-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.